PRESCRIPTION MEDICINE. Use only under the direction of a registered medical practitioner.
Intra Life generated product registryPRESCRIPTION · RxOfficial Intra Life brand information

Avanafil Tablets

AVAJOSH-100 TABS

Avanafil 100 mgTablets

The official product source lists Erectile Dysfunction (ED), Male Sexual Performance Support, Difficulty in Achieving Erection, Difficulty in Maintaining Erection, Performance Confidence Support. This page does not independently expand or validate those uses.

Avanafil 100 mg
Composition
Tablets
Dosage form
10 x 1 x 4 Tablets
Pack
2026-07-22
Last reviewed

Verified source information only. Confirm the current physical pack and locally approved information before use.

Source governed
Medical review gate active
AVAJOSH-100 TABS verified official product image
Official product visual
Verified official product image retained with generated version 2.

Verified product record

One source of truth for AVAJOSH-100 TABS

Public statements are limited to the approved evidence and review status recorded for this brand.

Generic

Avanafil

Composition

Avanafil 100 mg

Therapeutic class

Erectile Dysfunction (PDE5 Inhibitor)

Pack

10 x 1 x 4 Tablets

Medical information

Evidence-aligned, safety-first explanation

Approved indication

Approved official product evidence displays: Erectile Dysfunction (ED); Male Sexual Performance Support; Difficulty in Achieving Erection; Difficulty in Maintaining Erection; Performance Confidence Support. Current local approved information governs clinical use.

Mechanism of action

Packing: ( 10X1X4 ) Pack Type: tab Enquire Now Description Avanafil 100mg Tablets Suppliers across India - Intra Life Product Overview AvaJosh 100 Tablets by Intra Life is an advanced erectile dysfunction treatment containing Avanafil 100mg, a fast-acting PDE5 inhibitor specially designed to improve blood flow and help men achieve and maintain stronger erections during sexual activity.

Stewardship

Use only according to current approved local product information and qualified medical advice. Do not infer unsupported indications, dosing, performance, or outcomes from this page.

Dosage and administration

What the approved evidence says

Usually taken 15–30 minutes before sexual activity; Take as directed by the physician; Swallow with water; Do not exceed prescribed dosage Actual use must follow a registered medical practitioner and current local approved product information.

Administration guidance

Usually taken 15–30 minutes before sexual activity; Take as directed by the physician; Swallow with water; Do not exceed prescribed dosage

Prescription safeguard: This guide reproduces reviewed product evidence; it is not a personalized dose recommendation. Follow a registered medical practitioner and the current locally approved pack or insert.

Warnings and precautions

  • Avoid excessive alcohol consumption for better effectiveness
  • Do not exceed prescribed dosage
  • Sexual stimulation is required for effectiveness
  • Store in a cool and dry place
  • Follow medical advice strictly

Common adverse effects

  • Not supplied in the approved generated evidence; review current local prescribing information.

Relevant professional contexts

Registered Medical PractitionerHospital & Clinical PharmacyInstitutional Procurement

Professional and commercial pathways

A qualified route for every buyer

Start an enquiry

distribution

Discuss AVAJOSH-100 TABS trade and territory requirements

Share your territory, firm type, and expected business requirement for an appropriate Intra Life trade follow-up.

Use this enquiry path

distribution

Connect for authorized distribution information

Submit your market, licence-ready organization context, and procurement requirement for business verification.

Use this enquiry path

distribution

Request verified brand and composition information

Use the enquiry path to discuss AVAJOSH-100 TABS composition, pack, supply-channel requirements, and territory.

Use this enquiry path

distribution

Route a stockist or supply-chain enquiry

Provide your location and organization details so the relevant team can verify the appropriate supply route.

Use this enquiry path

retail

Verify the appropriate pharmacy supply route

Pharmacies can share their organization and location for product, pack, and supply-channel information. No online stock claim is made on this page.

Use this enquiry path

institutional

Request institutional product information

Hospital and institutional teams can submit formulary, pack, documentation, or procurement enquiries for review by the appropriate Intra Life team.

Use this enquiry path

Over 46 years of trust

Intra Life's current official homepage describes a legacy of over 46 years. This prototype uses that current wording and avoids older 43- or 45-year anniversary artwork found in other first-party materials.

Verify corporate source

Quality built through a carefully selected manufacturing network

Intra Life's official website presents a broad manufacturer network that includes established pharmaceutical production partners. The logos below reproduce the current official homepage carousel for corporate-network context only.

This corporate statement does not assign a certification, factory, or legal manufacturer to AVAJOSH-100 TABS. Product-specific manufacturer and marketer details remain subject to current pack-panel verification.

Frequently asked questions

Clear answers from approved evidence

Evidence register

Reviewed sources

Intra Life product directory

Continue to another governed authority page for source-linked composition, medical context, dosage information, safety boundaries, and professional enquiry routes.

Only live static brands and current Go-Live-Ready generated releases are listed. Drafts, blocked versions, and archived releases remain excluded.

INTRA LIFE

This evidence-grounded page provides product and trade information. It does not diagnose, prescribe, or replace the current approved pack insert and professional medical advice.

AVAJOSH-100 TABS

Information reviewed: 2026-07-22

Next scheduled review: 2026-10-20